phentermine-topiramate and glp-1 receptor agonists Qsymia vs Wegovy Mapping the effectiveness and risks

Continuous use year-round at maintenance doses (0.5mg twice weekly) has been reported in research contexts for up to 24 months without tolerance development or cumulative adverse events beyond those seen in short-term protocols

When it comes to transforming your body, we all know that diet and exercise are key

Medicina 58 , 340 (2022)

Both share theoretical concerns about pancreatitis (rare) and gallbladder events (related to rapid weight loss)

Recent research has demonstrated that liraglutide boosts the antitumor function of NK cells by inhibiting IL-6/STAT3 signal transduction

A gut butyrate-producing bacterium Butyricicoccus pullicaecorum regulates short-chain fatty acid transporter and receptor to reduce the progression of 1,2-dimethylhydrazine-associated colorectal cancer